We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Late extended adjuvant treatment with letrozole improves outcome in women with early-stage breast cancer who complete 5 years of tamoxifen.
- Authors
Goss, Paul E; Ingle, James N; Pater, Joseph L; Martino, Silvana; Robert, Nicholas J; Muss, Hyman B; Piccart, Martine J; Castiglione, Monica; Shepherd, Lois E; Pritchard, Kathleen I; Livingston, Robert B; Davidson, Nancy E; Norton, Larry; Perez, Edith A; Abrams, Jeffrey S; Cameron, David A; Palmer, Michael J; Tu, Dongsheng
- Abstract
The National Cancer Institute of Canada Clinical Trials Group MA.17 trial examined the efficacy of letrozole (LET) started within 3 months of 5 years of adjuvant tamoxifen in postmenopausal hormone receptor-positive early-stage breast cancer. When the trial was unblinded, patients who received placebo (PLAC) were offered LET.
- Publication
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Vol 26, Issue 12, p1948
- ISSN
1527-7755
- Publication type
Journal Article
- DOI
10.1200/JCO.2007.11.6798